HKG:2591 Revenue

In the year 2025, Guangzhou Innogen Pharmaceutical Group had annual revenue of 131.51M CNY. Guangzhou Innogen Pharmaceutical Group had revenue of 75.06M in the half year ending December 31, 2025.

Revenue

131.51M CNY

Revenue Growth

n/a

P/S Ratio

47.57

Revenue / Employee

681.39K CNY

Employees

193

Market Cap

6.96B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	131.51M	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition